• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质量源于设计:讨论与评估固体分散体风险

Quality by design: discussing and assessing the solid dispersions risk.

作者信息

Chaves Luise L, Vieira Alexandre C C, Reis Salette, Sarmento Bruno, Ferreira Domingos C

机构信息

Department of Applied Chemistry, Faculty of Pharmacy - University of Porto, Rua Jorge Viterbo Ferreira, 228, Edifício 3, piso 2, Postal Code: 4050-313 Porto, Portugal.

出版信息

Curr Drug Deliv. 2014;11(2):253-69. doi: 10.2174/1567201811666140211110943.

DOI:10.2174/1567201811666140211110943
PMID:24517867
Abstract

The poor water solubility tops the list of undesirable physicochemical properties in the drug discovery and Solid Dispersions (SDs) has been frequently used to enhance dissolution of such compounds. Although, some challenges limit the studies of SD commercial application. During recent years, the Quality by Design (QbD) approach has begun to change drug development, and focus on pharmaceutical production, which shifted from an univariate empirical understanding for a systematic multivariate process. In this review, some possible variables during the development process, formulation and production of SDs were defined, introducing and applying the QbD concept. The proposed work presented important definitions as well as its application in the pharmaceutical product and process design, especially the challenges encountered during the development of formulations of poorly soluble drugs. In this aspect, the SD technique was deeply discussed, in which some important parameters during SD design and production were mentioned as method of production, polymers commonly used, methods for characterization and stability evaluation, in addition of biopharmaceutical considerations. Finally, a specific risk assessment for the design and production of SD and critical points were discussed, which was a positive evolution and may lead to better understanding of SD for a rational formulation.

摘要

在药物研发中,水溶性差是最不理想的物理化学性质之一,而固体分散体(SDs)已被频繁用于提高此类化合物的溶出度。然而,一些挑战限制了固体分散体商业应用的研究。近年来,质量源于设计(QbD)方法已开始改变药物研发,并聚焦于药物生产,这一过程从单变量的经验性理解转变为系统性的多变量过程。在本综述中,定义了固体分散体研发过程、制剂和生产过程中的一些可能变量,介绍并应用了QbD概念。所提出的工作给出了重要定义及其在药品和工艺设计中的应用,特别是在难溶性药物制剂研发过程中遇到的挑战。在这方面,对固体分散体技术进行了深入讨论,其中提到了固体分散体设计和生产过程中的一些重要参数,如生产方法、常用聚合物、表征方法和稳定性评估,以及生物药剂学方面的考虑。最后,讨论了固体分散体设计和生产的特定风险评估及关键点,这是一个积极的进展,可能有助于更合理地理解固体分散体以进行制剂设计。

相似文献

1
Quality by design: discussing and assessing the solid dispersions risk.质量源于设计:讨论与评估固体分散体风险
Curr Drug Deliv. 2014;11(2):253-69. doi: 10.2174/1567201811666140211110943.
2
Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.聚合物无定形固体分散体:生物药剂学分类系统II类药物的非晶化、结晶、稳定化、固态表征及水相增溶综述
J Pharm Sci. 2016 Sep;105(9):2527-2544. doi: 10.1016/j.xphs.2015.10.008. Epub 2016 Jan 23.
3
Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.包含难溶性药物的固体分散体的当前趋势和未来展望。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):799-813. doi: 10.1016/j.ejpb.2013.09.007. Epub 2013 Sep 18.
4
Solubilization of poorly water-soluble drugs using solid dispersions.使用固体分散体增溶难溶性药物。
Recent Pat Drug Deliv Formul. 2013 Aug;7(2):122-33. doi: 10.2174/1872211311307020004.
5
Application of spray-drying and electrospraying/electospinning for poorly water-soluble drugs: a particle engineering approach.喷雾干燥和电喷雾/静电纺丝在难溶性药物中的应用:一种颗粒工程方法。
Curr Pharm Des. 2014;20(3):325-48. doi: 10.2174/13816128113199990399.
6
Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.喷雾干燥分散体在药物早期研发中的应用:理论与实践挑战
AAPS J. 2017 Mar;19(2):321-333. doi: 10.1208/s12248-016-0017-9. Epub 2016 Nov 28.
7
Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.固体分散体,第 I 部分:提高难溶性药物溶出度的制造方法的最新进展和未来机遇。
Expert Opin Drug Deliv. 2011 Nov;8(11):1501-19. doi: 10.1517/17425247.2011.618181. Epub 2011 Sep 16.
8
Amorphous Solid Dispersions: Utilization and Challenges in Drug Discovery and Development.无定形固体分散体:药物研发中的应用与挑战
J Pharm Sci. 2015 Oct;104(10):3237-58. doi: 10.1002/jps.24541. Epub 2015 Jul 14.
9
Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.固体分散体的分类:与(i)稳定性和溶解性(ii)制备及表征技术的相关性
Drug Dev Ind Pharm. 2015;41(9):1401-15. doi: 10.3109/03639045.2015.1018274. Epub 2015 May 20.
10
Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates.固体分散体:提高难溶性药物溶出度的策略及技术进展
Expert Opin Drug Deliv. 2012 Nov;9(11):1419-40. doi: 10.1517/17425247.2012.732064. Epub 2012 Oct 8.

引用本文的文献

1
Hot-Melt Extrusion: a Roadmap for Product Development.热熔挤出:产品开发路线图。
AAPS PharmSciTech. 2021 Jun 17;22(5):184. doi: 10.1208/s12249-021-02017-7.
2
Drug Delivery Systems on Leprosy Therapy: Moving Towards Eradication?麻风病治疗中的药物递送系统:朝着根除目标迈进?
Pharmaceutics. 2020 Dec 11;12(12):1202. doi: 10.3390/pharmaceutics12121202.
3
Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.无定形固体分散体:制备、表征、生物利用度机制、稳定性、监管考虑因素和上市产品的更新。
Int J Pharm. 2020 Aug 30;586:119560. doi: 10.1016/j.ijpharm.2020.119560. Epub 2020 Jun 18.
4
The Self-Assembly Phenomenon of Poloxamers and Its Effect on the Dissolution of a Poorly Soluble Drug from Solid Dispersions Obtained by Solvent Methods.泊洛沙姆的自组装现象及其对通过溶剂法获得的固体分散体中难溶性药物溶出度的影响。
Pharmaceutics. 2019 Mar 19;11(3):130. doi: 10.3390/pharmaceutics11030130.